Skip to main content
Search
Donate Blood
(Opens in a new tab/window)
About NBA
News and updates
Resources
BloodPortal login
(Opens in a new tab/window)
Close
Blood Products
Supply System
Clinical Guidance
Data and Research
Patient Information
Search
Search
Donate Blood
(Opens in a new tab/window)
About NBA
News and updates
Resources
BloodPortal login
(Opens in a new tab/window)
Blood Products
Blood Products
National Product Price List
Fresh Blood Products
Albumin Products
Clotting Factor and Other Products
Immunoglobulin Products
Immunoglobulin Usage and Data
Intravenous Immunoglobulin (IVIg)
Subcutaneous Immunoglobulin (SCIg)
Normal Human Immunoglobulin (NHIg)
Hyperimmune Immunoglobulin Products
Access and Ordering
BloodSTAR for Ig Products
BloodSTAR Registration Form
BloodNet for Blood Products from Lifeblood
BloodNet System Interface
Frequently Asked Questions
Blood Product Management
Inventory Management
Blood Product Wastage
Blood and Inventory Management Resources
Case Studies
Single Unit Transfusion Guide
Supply System
Supply System
Managing Blood Supply
Risk Management
National Stewardship Program
Blood Product Labelling
Governance for Immunoglobulin Products
National Immunoglobulin Governance Committees
Criteria for Immunoglobulin Products
Suppliers and Commercial Supply Contracts
Fresh Blood Product Supply and Lifeblood
Plasma and Recombinant Product Supply
Imported Product Supply
Red Cell Diagnostic Product Supply
Australian Health Provider Access to Blood and Blood Products
Overseas Supply of Blood Products
Clinical Guidance
Clinical Guidance
Rh D Ig Guideline
PBM Guidelines
National Standards
Immunoglobulin
Patient Blood Management
Transfusion-related Adverse Events
Bleeding Disorders
Australian Bleeding Disorders Registry (ABDR)
eLearning Courses
Public Consultations
Patient Blood Management Guidelines
Data and Research
Data and Research
Data and Reporting
Research Funding Program
Successful Grant Rounds
Patient Information
Patient information
Bleeding disorders
Blood disorders
Travelling with blood products
MyABDR app and the ABDR
News and updates
Home
News and updates
All
2024
2023
2022
2021
2020
2019
National supply arrangements for Hemlibra (emicizumab)
On 2 November 2020, Hemlibra became available under national supply arrangements.
02 Nov 2020
Update for IG Criteria: Neurology
We developed the Criteria for the clinical use of immunoglobulin in Australia (the Criteria) using specialist working groups of expert clinicians to identify th
01 Mar 2020